Jim Simons Dr Reddys Laboratories LTD Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 9,195,228 shares of RDY stock, worth $136 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

9,195,228

Previous 9,418,428 2.37%

Holding current value

$136 Million

Previous $149 Million 18.45%

% of portfolio

0.19%

Previous 0.23%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$12.53 - $15.81 $2.8 Million - $3.53 Million	-223,200 Reduced 2.37%	9,195,228 $121 Million
Q4 2024 Feb 13, 2025	BUY	$13.99 - $79.75 $104 Million - $596 Million	7,467,979 Added 382.89%	9,418,428 $149 Million
Q3 2024 Nov 13, 2024	SELL	$75.41 - $84.21 $3.4 Million - $3.79 Million	-45,046 Reduced 2.26%	1,950,449 $155 Million
Q2 2024 Aug 09, 2024	BUY	$68.26 - $76.19 $4.48 Million - $5 Million	65,606 Added 3.4%	1,995,495 $152 Million
Q1 2024 May 13, 2024	BUY	$67.36 - $77.59 $4.65 Million - $5.36 Million	69,094 Added 3.71%	1,929,889 $142 Million
Q4 2023 Feb 13, 2024	BUY	$64.27 - $69.9 $1.63 Million - $1.77 Million	25,371 Added 1.38%	1,860,795 $129 Million
Q3 2023 Nov 14, 2023	BUY	$61.9 - $72.77 $11.6 Million - $13.7 Million	188,200 Added 11.43%	1,835,424 $123 Million
Q2 2023 Aug 11, 2023	SELL	$53.34 - $63.11 $1.47 Million - $1.74 Million	-27,600 Reduced 1.65%	1,647,224 $104 Million
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $521,463 - $574,993	10,100 Added 0.61%	1,674,824 $95.3 Million
Q4 2022 Feb 13, 2023	SELL	$51.15 - $57.45 $5.58 Million - $6.27 Million	-109,114 Reduced 6.15%	1,664,724 $86.1 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $13.2 Million - $15.1 Million	-263,900 Reduced 12.95%	1,773,838 $92.8 Million
Q2 2022 Aug 12, 2022	BUY	$49.62 - $58.13 $6.23 Million - $7.3 Million	125,500 Added 6.56%	2,037,738 $113 Million
Q1 2022 May 13, 2022	SELL	$48.27 - $65.25 $120,675 - $163,125	-2,500 Reduced 0.13%	1,912,238 $107 Million
Q4 2021 Feb 11, 2022	SELL	$59.5 - $67.25 $4.38 Million - $4.95 Million	-73,600 Reduced 3.7%	1,914,738 $125 Million
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $1.01 Million - $1.26 Million	-16,800 Reduced 0.84%	1,988,338 $130 Million
Q2 2021 Aug 13, 2021	SELL	$62.12 - $74.2 $1.99 Million - $2.37 Million	-32,000 Reduced 1.57%	2,005,138 $147 Million
Q1 2021 May 13, 2021	SELL	$57.98 - $73.08 $12.4 Million - $15.6 Million	-214,100 Reduced 9.51%	2,037,138 $125 Million
Q4 2020 Feb 10, 2021	SELL	$62.61 - $71.29 $6.96 Million - $7.92 Million	-111,100 Reduced 4.7%	2,251,238 $160 Million
Q3 2020 Nov 13, 2020	BUY	$51.39 - $72.41 $534,456 - $753,064	10,400 Added 0.44%	2,362,338 $164 Million
Q2 2020 Aug 13, 2020	BUY	$39.55 - $54.65 $14.1 Million - $19.5 Million	356,890 Added 17.89%	2,351,938 $125 Million
Q1 2020 May 14, 2020	BUY	$34.75 - $45.85 $9.94 Million - $13.1 Million	286,166 Added 16.75%	1,995,048 $80.5 Million
Q4 2019 Feb 13, 2020	BUY	$36.66 - $41.78 $8.45 Million - $9.63 Million	230,400 Added 15.58%	1,708,882 $69.3 Million
Q3 2019 Nov 13, 2019	BUY	$34.82 - $39.26 $9.75 Million - $11 Million	279,882 Added 23.35%	1,478,482 $56 Million
Q2 2019 Aug 12, 2019	BUY	$36.05 - $42.76 $4.85 Million - $5.76 Million	134,600 Added 12.65%	1,198,600 $44.9 Million
Q1 2019 May 14, 2019	BUY	$35.77 - $40.57 $1.74 Million - $1.97 Million	48,600 Added 4.79%	1,064,000 $43.1 Million
Q4 2018 Feb 13, 2019	BUY	$31.89 - $38.44 $32.4 Million - $39 Million	1,015,400 New	1,015,400 $38.3 Million

Others Institutions Holding RDY

# of Institutions

263

Shares Held

98.8M

Call Options Held

12.5K

Put Options Held

800

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.45B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account